Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia
Ann Janssens, Marc Boogaerts, Gregor VerhoefDepartment of Hematology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, BelgiumAbstract: Fludarabine is an antineoplastic agent used in the treatment of hematological malignancies, particularly chronic lymphocytic leukemia (CLL) and indolent B-...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-10-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/development-of-fludarabine-formulations-in-the-treatment-of-chronic-ly-a3622 |